Biotech Startups

Carrick Therapeutics is a biopharmaceutical company with a leadership team experienced in oncology drug development and commercialization. The company focuses on developing and advancing cancer treatments through clinical development and business development activities.

5 investors

Cellares develops automated manufacturing systems and technology platforms to accelerate the production and commercialization of cell therapies. The company serves biopharmaceutical manufacturers and cell therapy developers worldwide.

5 investors

5 investors

Cellular Intelligence develops cell therapy treatments, specifically acquiring STEM-PD, a Phase 2-ready therapy for Parkinson's disease. The company focuses on cell fate engineering to design biological solutions for neurological diseases.

5 investors

CellVoyant is an AI-first company that develops predictive analytics and optimization tools for cell-based therapeutic development, helping researchers accelerate process development and reduce costs through label-free imaging analysis and data-driven process optimization.

5 investors

Cerevance is a clinical-stage drug discovery and development company developing non-dopaminergic, orally-delivered therapies for brain and central nervous system disorders, including Parkinson's disease, schizophrenia, Alzheimer's disease, and ALS. It uses a proprietary human brain tissue profiling platform (NETSseq) and advances candidates such as solengepras (CVN424), CVN293, and CVN766 through clinical trials.

5 investors

Checkpoint Surgical develops intraoperative nerve stimulation devices, biomaterial implants, and surgical instruments for peripheral nerve and tendon surgery. The company produces ACMShield, a dehydrated placental membrane allograft used as a protective barrier in surgical applications.

5 investors

ChromaCode develops a High-Definition PCR (HDPCR) multiplexing platform that enables genomic solutions for oncology and precision medicine, offering faster results and cost-effective workflows through automated interpretation and cloud-based software.

5 investors

CircNova uses artificial intelligence to generate, analyze, and identify circular RNA structures for therapeutic development. The company focuses on non-coding RNA therapeutics targeting previously undruggable disease targets and major unmet clinical needs.

5 investors

Citruslabs is a clinical research organization that designs and runs consumer perception studies, clinical trials, and randomized controlled trials for health and wellness brands including supplements, skincare, pet health, biotech, and functional foods. The company translates study results into marketing-ready, regulator-reviewed product claims for consumer health brands that traditionally lack access to affordable clinical evidence.

5 investors

Coherence develops neurotechnology systems that measure and modulate brain activity to treat cancer and other neurological diseases. The company uses bioelectronic interfaces and AI to decode the body's neural signals and enable precise, adaptive therapeutic interventions.

5 investors

Harvard University is a higher-education and research institution whose schools and faculty conduct medical and scientific research across areas such as chronic disease, public health, and engineering. The page highlights research on conditions including cardiovascular disease, chronic pain, lung disease, and tissue engineering.

5 investors

COUR develops antigen-specific immunotherapies that reprogram the immune system to treat the underlying causes of autoimmune and immune-mediated diseases while preserving normal immune function. The company is advancing a pipeline of disease-modifying therapies aimed at patients with a range of autoimmune conditions.

5 investors

Crown Bioscience is a contract research organization (CRO) providing preclinical and translational research services in oncology and immuno-oncology drug discovery, including a large library of cancer models such as PDX, cell line derived xenografts, syngeneic, and in vitro models. It serves biotech and pharmaceutical companies conducting drug development research.

5 investors

Cullinan Therapeutics develops clinical-stage T cell engager therapies targeting autoimmune diseases and cancer, leveraging immune modulation expertise to advance high-impact therapeutic candidates.

5 investors

Cytospire Therapeutics develops multispecific antibodies and next-generation γδ T cell engagers designed to direct innate and adaptive immune effector cells as an alternative to CD3-based engagers. The company is building a portfolio of immune cell engagers aimed at cancer therapies.

5 investors

Dawaai is a licensed online pharmacy and healthcare group that procures medicines directly from manufacturers and distributors and delivers them to patients' doorsteps, including a two-hour "Fast" delivery service. It operates in Pakistan, serving retail pharmacy customers with pharmacist-handled medicine ordering and delivery.

5 investors

Dewpoint Therapeutics develops condensate-modulating drugs by using an integrated platform that maps, measures, and modulates biomolecular condensates to identify druggable targets and disease mechanisms. Its discovery engine combines biology, chemistry, proprietary datasets, and AI to pursue therapies for complex diseases, including previously undruggable targets.

5 investors

Dimension Bio is a biotechnology company that designs and manufactures regenerative therapeutics using its BioNidum™ platform to restore tissue function lost to disease, trauma, or aging. The platform combines materials science, 3D printing, and digital manufacturing to create biosynthetic and biohybrid scaffolds for implantable and injectable products across sports medicine, orthopedics, plastic surgery, dental, and cell therapy applications.

5 investors

Draig Therapeutics is a clinical-stage biotech company developing neuromodulator therapies for neuropsychiatric disorders such as major depressive disorder. Its lead program, DT-101, is a Phase 2 AMPA receptor potentiator, and it is also advancing selective GABAA receptor modulators.

5 investors

DUDE CHEM develops computational chemistry and digitalization tools for sustainable chemical manufacturing, using green chemistry principles to reduce waste and hazardous substances in the production of chemicals, starting materials, and pharmaceutical ingredients (APIs).

5 investors

Biotechnology company using multiplex gene editing to develop genetically engineered porcine organs for human transplantation.

5 investors

Elypta develops a metabolism-based liquid biopsy that measures the GAGome, a set of biomarkers of tumor metabolism, and applies machine learning to noninvasively detect cancer signatures. The company focuses on early cancer detection to reduce cancer mortality.

5 investors

EndoGastric Solutions offers the Transoral Incisionless Fundoplication (TIF 2.0) procedure and the EsophyX device used to treat GERD, along with reimbursement and technical/administrative support (TAP program) for medical practices. The company, now associated with Merit Medical, serves gastroenterology and surgical providers performing anti-reflux procedures.

5 investors